Hyun-Sung Lee

19PUBLICATIONS
89CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jan 09, 2026
Tumor-infiltrating natural killer cell profiling for therapeutic stratification in patients with resectable non-small cell lung cancer.

Atsushi Ito, Sung Wook Kang, Hee-Jin Jang

|Apr 10, 2025
Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma.

Hee-Jin Jang, Meera Patel, Daniel Y Wang

|Feb 12, 2025
MAGE-A4 induces non-small cell lung cancer and tumor-promoting plasma cell accumulation.

Dominique Armstrong, Cheng-Yen Chang, Monica J Hong

|Feb 24, 2024
Clonal gene signatures predict prognosis in mesothelioma and lung adenocarcinoma.

Yupei Lin, Bryan M Burt, Hyun-Sung Lee

|Dec 05, 2022
A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma.

Hyun-Sung Lee, Hee-Jin Jang, Maheshwari Ramineni

Pageof 4